Reveal LINQ Insertable Cardiac Monitor vs AVIEW
AI Verdict
Choose Reveal LINQ Insertable Cardiac Monitor if…
Choose the Reveal LINQ Insertable Cardiac Monitor if you require long-term, continuous, and highly accurate heart rhythm monitoring for conditions like atrial fibrillation or unexplained syncope. Its implantable nature and AccuRhythm AI algorithms are specifically designed to reduce false alerts and enhance diagnostic yield over an extended period, minimizing patient burden and improving diagnostic efficiency.
View Reveal LINQ Insertable Cardiac Monitor →Choose AVIEW if…
Choose AVIEW if your practice focuses on comprehensive AI-driven analysis of CT scans for the early detection and monitoring of lung cancer, COPD, and coronary artery calcification. This platform excels at providing detailed quantitative assessments, automating workflow integration with existing PACS/RIS systems, and offering advanced 3D visualizations for multiple thoracic pathologies.
View AVIEW →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Reveal LINQ Insertable Cardiac Monitor | AVIEW |
|---|---|---|
| Pricing | Contact vendor | Subscription; one-off payment |
| Deployment | Implantable device with data transmitted to a cloud-based platform (CareLink™ network) via patient smartphone app or home communicator. | Cloud-based; Hybrid solution; Locally on dedicated hardware; Locally virtualized (virtual machine, Docker) |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AVIEWAVIEW offers extensive workflow automation and seamless integration with existing PACS/RIS/CIS systems, directly enhancing the daily usability for radiologists. Its multiple deployment options also provide flexibility for IT departments. While Reveal LINQ II simplifies patient data transmission, AVIEW's direct impact on clinical workflow efficiency and diagnostic reporting gives it an edge in usability for healthcare professionals.
Clinical Value
AVIEWAVIEW offers a broader spectrum of diagnostic capabilities across multiple critical conditions, including lung cancer, COPD, and coronary artery disease, from a single CT scan. Its detailed quantitative analysis, risk stratification, and automated reporting significantly enhance diagnostic precision and early detection. While Reveal LINQ II provides crucial long-term cardiac monitoring, AVIEW's comprehensive multi-disease approach offers a wider scope of clinical impact.
Pricing & Value
AVIEWAVIEW offers transparent pricing models, including subscription and one-off payment options, with costs based on installations or users. This clarity allows healthcare organizations to better understand and budget for the solution. In contrast, Reveal LINQ II's pricing is undisclosed and requires direct vendor contact, making it difficult to assess its value proposition upfront.
Enterprise Readiness
AVIEWAVIEW demonstrates superior enterprise readiness through its highly flexible deployment options, including cloud, hybrid, local hardware, and virtualized solutions, catering to diverse IT infrastructures. Its explicit integration with PACS/RIS/CIS systems ensures seamless adoption into existing clinical workflows. While Reveal LINQ II leverages Medtronic's established CareLink network, AVIEW's adaptability to various enterprise environments provides a distinct advantage.
Innovation
AVIEWAVIEW showcases broader innovation by integrating multiple AI-powered diagnostic capabilities into a single platform for comprehensive analysis of CT scans, covering lung cancer, COPD, and coronary artery calcification. Its ability to perform multi-organ analysis, detailed quantification, and advanced visualizations represents a significant leap in diagnostic imaging. While Reveal LINQ II's AccuRhythm AI for false alert reduction is innovative for ICMs, AVIEW's scope of AI application is more expansive.
Support & Docs
Reveal LINQ Insertable Cardiac MonitorMedtronic, as a global leader in medical technology, is expected to have a highly established and comprehensive support infrastructure, including extensive documentation, training, and technical assistance for both clinicians and patients using implantable devices like the Reveal LINQ II. While Coreline Soft likely offers professional support for AVIEW, Medtronic's long-standing presence and global reach typically translate to a more mature and robust support ecosystem.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Reveal LINQ Insertable Cardiac Monitor | AVIEW |
|---|---|---|
| Name | Reveal LINQ Insertable Cardiac Monitor | AVIEW |
| Company | Medtronic | Coreline Soft Co. |
| Description | The Medtronic LINQ IIu2122 Insertable Cardiac Monitor (ICM) with AccuRhythmu2122 AI algorithms provides long-term, accurate heart monitoring by using deep learning AI to reduce false alerts and enhance diagnostic yield for conditions like atrial fibrillation and syncope. | Coreline Soft's AVIEW AI platform offers comprehensive solutions for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans, enhancing diagnostic precision and streamlining radiology workflows. |
| Categories | Cardiology AI, Wearables & Remote Monitoring (RPM) | Cardiology AI, Oncology AI, Radiology & Imaging AI |
| Specialties | Cardiology, Pediatrics | Cardiology, Pulmonology, Radiology |
| Key Features | AccuRhythmu2122 AI algorithms for reduced false alerts (AF and Pause), 4.5-year battery longevity (nominal settings), Continuous, long-term subcutaneous ECG monitoring, Remote programming capabilities, Enhanced ECG experience for clinical adjudication, MyCareLink Heartu2122 mobile app for patient data transmission, MyCareLink Relayu2122 home communicator for data transmission, MRI compatible (at u2264 3T with no post-insertion waiting) | AI-powered lung nodule detection and characterization (size, volume, type, location, Lung-RADS score), Emphysema quantification and low attenuation area (LAA) analysis, Coronary artery calcium (CAC) scoring (Agatston, volume, mass score, risk stratification), Automated segmentation of lung lobes, airways, vessels, and coronary arteries, 3D visualizations and comprehensive PDF reports, Workflow automation and integration with PACS/RIS/CIS, Follow-up registration and nodule matching for serial CT scans, Interstitial Lung Disease (ILD) pattern analysis (AVIEW Lung Texture) |
Videos
Demos, reviews, and walkthroughs featuring Reveal LINQ Insertable Cardiac Monitor and AVIEW.